A 55-year-old farmer from rural India presents with a 1.5 cm erythematous, scaly, indurated plaque on the lower lip with a history of chronic sun exposure and tobacco use. Histopathology confirms moderately differentiated squamous cell carcinoma. The lesion is localized without nodal involvement. Surgery is planned, but the patient also wishes adjuvant topical therapy to reduce recurrence risk. What is the drug of choice for adjuvant topical application?

Explanation

## Adjuvant Topical Therapy for High-Risk SCC **Key Point:** Topical 5-fluorouracil (5-FU) is the gold-standard adjuvant topical agent for high-risk squamous cell carcinoma after surgical excision, particularly for lip SCC and lesions with aggressive histology. ### Mechanism and Clinical Rationale 5-FU is a pyrimidine antimetabolite that inhibits thymidylate synthase, disrupting DNA synthesis in rapidly dividing cells. When applied topically: - Penetrates superficial dermis and subcutaneous tissue. - Destroys residual dysplastic cells and field cancerization. - Reduces local recurrence and second primary tumors in high-risk patients. ### Evidence for Adjuvant Use - **Landmark trials**: Topical 5-FU (0.5–5%) applied for 2–4 weeks post-operatively reduces recurrence in high-risk SCC (>4 mm depth, poor differentiation, perineural invasion, lip location). - Particularly effective for **lip SCC** (vermilion border), where field cancerization is common. - Typical regimen: 5% cream or solution applied twice daily for 2–4 weeks; causes controlled inflammation and epithelial necrosis of dysplastic foci. ### Comparison of Topical Agents | Agent | Indication | Mechanism | Role in SCC | |-------|-----------|-----------|-------------| | **5-Fluorouracil** | High-risk SCC, field cancerization | Antimetabolite (thymidylate synthase inhibitor) | **Adjuvant first-line** | | Tretinoin | Photoaging, actinic keratosis | Retinoid (vitamin A derivative) | Preventive only, not adjuvant | | Adapalene | Acne, photoaging | Retinoid (naphthoic acid derivative) | Preventive only, not adjuvant | | Azelaic acid | Rosacea, post-inflammatory hyperpigmentation | Antimicrobial, anti-inflammatory | No role in SCC | **High-Yield:** Topical 5-FU is the **only topical agent with proven adjuvant efficacy** in reducing recurrence of high-risk SCC after surgery. Retinoids (tretinoin, adapalene) are used for **prevention** of actinic keratosis and field cancerization, not adjuvant treatment of established SCC. **Clinical Pearl:** Lip SCC (as in this case) is particularly aggressive due to the rich vascular supply, thin epithelium, and high field cancerization rate. Adjuvant 5-FU is strongly recommended. **Mnemonic:** **5-FU for SCC Adjuvant** — **5** (5-FU), **F** (Field cancerization), **U** (Unresectable/high-risk), **S** (Squamous), **C** (Carcinoma), **C** (Chemotherapy, topical). **Warning:** Do not confuse preventive retinoids (tretinoin, adapalene) with adjuvant chemotherapy. Retinoids reduce the risk of **new** actinic keratosis and SCC but do NOT reduce recurrence of **established** SCC after surgery.